Who owns Taysha Gene Therapies Inc (TSHA)? Superinvestor holders
4 superinvestors of the 157 tracked here hold Taysha Gene Therapies Inc (TSHA) in their latest 13F filing, with $201.1M between them. Peter Kolchinsky gives it the most weight: 1.39% of the reported portfolio. In their latest reported quarter, Polen Capital team added; Andrew Spokes reduced.
Key facts
- Superinvestors holding it
- 4 of 157
- Biggest holder
- Peter Kolchinsky, $160.4M
- Largest weight
- Peter Kolchinsky, 1.39%of their portfolio
- Combined value
- $201.1M
- Bought last quarter
- 1
- Sold last quarter
- 1
From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.
| # | Investor | Share of their portfolio | Value | Shares | Last quarter | Shares moved | Quarter |
|---|---|---|---|---|---|---|---|
| 1 | Peter KolchinskyRA Capital Management | 1.39% | $160.4M | 23.56M | No change | 0 | Q2 2026 |
| 2 | Julian and Felix BakerBaker Bros. Advisors | 0.14% | $27.3M | 4M | No change | 0 | Q2 2026 |
| 3 | Andrew SpokesFarallon Capital Management | 0.06% | $11M | 2.25M | ▼ Reduced 0.04% | −900 | Q3 2026 |
| 4 | Polen Capital teamPolen Capital Management | 0.03% | $2.5M | 503.38K | ▲ Added 2.9% | +14.14K | Q3 2026 |
Quarter by quarter
| Quarter | Filings in | Holders | Combined shares | Combined value | Bought | Sold |
|---|---|---|---|---|---|---|
| Q3 2026 | 92 | 2 | 2.75M | $13.4M | 1 | 1 |
| Q2 2026 | 157 | 4 | 30.3M | $206.3M | 2 | 0 |
| Q1 2026 | 157 | 3 | 27.88M | $124.6M | 1 | 0 |
| Q4 2025 | 157 | 3 | 27.72M | $152.4M | 1 | 0 |
| Q3 2025 | 157 | 2 | 27.56M | $90.1M | 0 | 0 |
| Q2 2025 | 157 | 2 | 27.56M | $63.7M | 1 | 0 |
| Q1 2025 | 156 | 2 | 14.88M | $20.7M | 0 | 0 |
| Q4 2024 | 156 | 2 | 14.88M | $25.7M | 0 | 0 |
A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.
Each holder's shares
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Andrew Spokes | 2.25M | 2.25M | — | — | — | — | — | — |
| Polen Capital team | 503.38K | 489.22K | 319.75K | 156.59K | — | — | — | — |
| Peter Kolchinsky | · | 23.56M | 23.56M | 23.56M | 23.56M | 23.56M | 10.87M | 10.87M |
| Julian and Felix Baker | · | 4M | 4M | 4M | 4M | 4M | 4M | 4M |
A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.
Questions and answers
Which superinvestors own TSHA?
In their latest 13F filings: Peter Kolchinsky (1.39% of the portfolio, $160.4M), Julian and Felix Baker (0.14% of the portfolio, $27.3M), Andrew Spokes (0.06% of the portfolio, $11M), Polen Capital team (0.03% of the portfolio, $2.5M).
Who bought TSHA last quarter?
Polen Capital team (added 2.9%). “Last quarter” is each investor's latest reported quarter.
Who sold TSHA last quarter?
Reduced: Andrew Spokes (0.0% fewer shares).
How current is this?
It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.
Learn
Cite this page
Funkfolio, “Who owns Taysha Gene Therapies Inc (TSHA)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/TSHA/superinvestors
Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.
Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to TSHA by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.